Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.22.2.2
Stockholders' Equity (Details) - USD ($)
 9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Stockholders' Equity (Details) [Line Items]    
Authorized to issue and sale of stock 17,000,000  
Common stock, shares authorized 12,000,000  
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares outstanding
Options to purchase common stock 53,200  
Stock options term 10 years  
Awardee over a period 4 years  
Weighted average exercise price expired (in Dollars) $ 56.39  
Warrant [Member]    
Stockholders' Equity (Details) [Line Items]    
Weighted average exercise price expired (in Dollars) $ 114.33  
Warrants purchase 9,600  
Shares of common stock 9,600  
Stock Option [Member]    
Stockholders' Equity (Details) [Line Items]    
Options to purchase common stock 19,400  
Weighted average exercise price granted (in Dollars per share) $ 10.42  
Aggregate grant fair value (in Dollars) $ 200,000  
Stock Option [Member] | 2011 plan [Member]    
Stockholders' Equity (Details) [Line Items]    
Remaining options to be issued 100,000